MorphoSys AG

MorphoSys AG, is a biotechnology company focused on the development of antibody-based products for the pharmaceutical industry.
The company is applying its proprietary HuCALŪ technology to generate new medicines for treating diseases such as cancer and inflammation. Because of its unique features, the HuCALŪ technology is the gold standard for antibody generation. The HuCALŪ technology enables MorphoSys to generate fully human antibodies precisely tailored to the intended application. Comprising over 10 billion distinct human antibodies, it is a vast resource of potential drugs.
Antibodies comprise one of the fastest-growing classes of medicines, having projected annual sales growth in excess of 25%.

Activity:

- Manufacturing

Product / Technology type(s) covered:

- Bio
- Technology

Therapeutic targets:

- Cancer
- Infectious Diseases

Markets Covered

a. HeadQuarter: Germany

b. Continent(s) active: Europe , North America

c. Countries active:

Corporate data:

Number of Employees: 105

Turnover:

Amount:	Year:	Currency:
16100000	2001	Euro

Year founded: 1992